Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-21

Clinical Trial Update: Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness

View source ↗

Summary

A clinical trial is evaluating postpartum use of the Stelo real-time continuous glucose monitor to support lifelong wellness in people with gestational diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelo Real-time Continuous Glucose Monitor

Snippet

Sponsor: Oregon Health and Science University | Conditions: Gestational Diabetes, Postpartum | Status: NOT_YET_RECRUITING